首页> 外文期刊>BMC Endocrine Disorders >Hyperuricemia and metabolic syndrome in type 2 diabetes mellitus patients at Hawassa university comprehensive specialized hospital, South West Ethiopia
【24h】

Hyperuricemia and metabolic syndrome in type 2 diabetes mellitus patients at Hawassa university comprehensive specialized hospital, South West Ethiopia

机译:2型糖尿病患者的高尿酸血症和代谢综合征夏至西南埃塞俄比亚综合专业医院患者

获取原文
           

摘要

Metabolic syndrome is a cluster of the most dangerous heart attack risk factors such as diabetes and prediabetes, abdominal obesity, high cholesterol and high blood pressure. Hyperuricemia is a condition in which the serum uric acid concentration is greater than 5.5?mg per deciliter for child and greater than 7.2 and 6.0?mg per deciliters for male and female adults respectively. A cross-sectional study was conducted to determine the magnitude of hyperuricemia and associated factors among type 2 diabetes mellitus patients at Hawassa Comprehensive Specialized Hospital (HCSH) from February 28 to May 30 /2017. A random sampling technique was used to include 319 study subjects and a signed consent had been provided by each study subject before running any data collection. An interviewer administered structured questionnaire was used to collect socio-demographic and some clinically useful data. In addition to this, we reviewed the records of the study subjects to obtain other useful clinical data. Five milliliter blood specimen was collected from each study subjects after overnight fasting. A25TM Bio-System Random Access chemistry analyzer was used for blood sample analysis. All data were checked visually, coded and entered into epi-data version 3.4 and statistical analysis was performed using SPSS version 20.0 software. Bi-variate and multivariate logistic regressions were used to determine the association between explanatory and the outcome variables. The prevalence of hyperuricemia and metabolic syndrome among type 2 diabetic patients in the study area were 33.8%(n?=?106) and 70.1% (n?=?220) respectively. Having age greater or equal to 45?years (AOR: 1.9, CI: 1.-3.2, P value =0.015) and having metabolic syndrome (AOR: 2.6, CI: 1.5–4.7, P value?=?0.001) were the determinant variables for hyperuricemia among type 2 diabetic patients. There was high prevalence of hyperuricemia among type 2 diabetic patients with high prevalence of metabolic syndrome. Therefore, regular health information about life style modification, early diagnosis and treatment for hyperuricemia and metabolic syndrome are essential to reduce hyperuricemia and metabolic syndrome in type 2 diabetic patients.
机译:代谢综合征是一种最危险的心脏病发作危险因素,如糖尿病和前脂肪酸,腹部肥胖,高胆固醇和高血压。高尿酸血症是儿童每分层血清尿酸浓度大于5.5Ω·mg,分别为男性和女性成年人的每解密剂大于7.2和6.0μmg。进行了横截面研究,以确定2月28日至2017年5月30日至5月30日至5月30日至5月30日至5月30日在夏季综合专业医院(HCSH)中糖尿病患者2型糖尿病患者中的高尿酸血症和相关因素的大小。随机采样技术用于包括319个研究科目,并且在运行任何数据收集之前,每个研究课程都提供了签署的同意。采访了一个面试官的结构化问卷,用于收集社会人口统计和一些临床有用的数据。除此之外,我们还审查了研究科目的记录,以获得其他有用的临床数据。在隔夜禁食后,从每项研究受试者收集五毫升血液标本。 A25TM生物系统随机接入化学分析仪用于血液样本分析。目视检查所有数据,编码并输入EPI-Data 3.4版,使用SPSS版本20.0软件进行统计分析。双变化和多变量逻辑回归用于确定解释性和结果变量之间的关联。研究面积2型糖尿病患者的高尿酸血症和代谢综合征的患病率分别为33.8%(n?=Δ106)和70.1%(n?= 220)。年龄较大或等于45?年(AOR:1.9,CI:1.2,P值= 0.015)并具有代谢综合征(AOR:2.6,CI:1.5-4.7,P值?= 0.001)是2型糖尿病患者的高尿酸血症的决定性变量。 2型糖尿病患者的高尿酸血症患者高患病患者患病率高。因此,常规健康信息有关寿命改性的早期诊断和治疗用于高尿酸血症和代谢综合征,对2型糖尿病患者的高尿血症和代谢综合征是必不可少的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号